Published Date: 02 Mar 2023
A group of medical researchers from Stanford University, together with colleagues from the Taiwan Biomedical Research Institute, have discovered a way to prevent or treat chronic lung disease. ...
Read Full NewsHCPLive previews GOLD 2026 in Philadelphia, November 5-6, with sessions on the 2027 GOLD Report, mucus plugging, and exacerbations, plus expert interviews.
7 Pulmonology Headlines You Missed in October
Nasal mRNA ETH47 Lowers Rhinovirus Load in Asthma Challenge Study
Q&A: Why 70% of COPD Goes Undiagnosed, With Alvar Agustí, MD
Mucus Plugs in COPD: Prevalence, Exacerbations, Mortality Risk
Richard Nowak, MD, director of the Yale Myasthenia Gravis Clinic and global principal investigator of the MINT trial, discusses open-label extension findings for inebilizumab, a CD19-directed B cell depleting therapy, in generalized myasthenia gravis.
uniQure presented final safety and biomarker results from the discontinued EPISOD1 trial of AMT-162, an investigational gene therapy for SOD1-associated ALS.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation